Clinical Trials

For more information, please email Beatriz Kohler regarding clinical trials: inr@jhmi.edu

Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma

The purpose of this study is to show that chemotherapy delivered directly through the artery supplying the eye (ophthalmic artery) in patients with retinoblastoma is a safe and effective treatment alternative to conventional systemic chemotherapy, external beam radiation, and enucleation (surgical removal of the eye).

Learn more

Familial Intracranial Aneurysm Study, FIA Study NIH

The Familial Intracranial Aneurysm Study, also known as the FIA study, is a collaborative research effort of neurologists and neurosurgeons throughout the United States, Canada, Australia, and New Zealand. These researchers are studying genetic and other risk factors which may be important in the development of intracranial aneurysms. This study is sponsored by the National Institutes of Health.    

Learn more

Interventional Management of Stroke, IMS III

The Interventional Management of Stroke (IMS III) Trial is a randomized, open-label multi-center study that will compare a combined intravenous (IV) and intra-arterial (IA) treatment approach to restoring blood flow to the brain to the current standard FDA approved treatment approach of giving IV rt-PA alteplase, Activase,® alone.

Learn more